Back
Leggett & Platt Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
29
LEG
Leggett & Platt
Last Price:
12.13
Seasonality Move:
5.87%
Sell
25
ASND
Ascendis Pharma AS
Last Price:
124.12
Seasonality Move:
11.25%
Sell
29
Leggett & Platt (LEG)
is a Sell
Is Leggett & Platt a Buy, Sell or Hold?
- The current Leggett & Platt [LEG] share price is $12.13. The Score for LEG is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- LEG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $124.33. The Score for ASND is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEG Stock Price Chart
What is Leggett & Platt's stock price today?
-
The Leggett & Platt share price today is $12.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEG is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $124.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
LEG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 42.34 | Sell |
| Chaikin Money Flow: | 628951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.13 - 13.11) | Sell |
| Bollinger Bands (100): | (11.73 - 13.19) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.39 | Sell |
| Relative Strength Index (14 RSI): | 40.9 | Sell |
| Chaikin Money Flow: | -343585 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.76 - 133.22) | Sell |
| Bollinger Bands (100): | (125.03 - 141.83) | Sell |
LEG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.17 | Sell |
| 20-day SMA: | 12.51 | Sell |
| 50-day SMA: | 12.71 | Sell |
| 200-day SMA: | 14.88 | Sell |
| 8-day EMA: | 12.23 | Sell |
| 20-day EMA: | 12.44 | Sell |
| 50-day EMA: | 12.63 | Sell |
| 200-day EMA: | 15.4 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.61 | Sell |
| 20-day SMA: | 127.56 | Sell |
| 50-day SMA: | 132.48 | Sell |
| 200-day SMA: | 137.31 | Sell |
| 8-day EMA: | 126.45 | Sell |
| 20-day EMA: | 128.47 | Sell |
| 50-day EMA: | 131.53 | Sell |
| 200-day EMA: | 130.72 | Sell |
Leggett & Platt Earnings Growth & LEG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.14 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.
Leggett & Platt Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||